These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 22507770)

  • 21. Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia.
    Yamaguchi H; Calado RT; Ly H; Kajigaya S; Baerlocher GM; Chanock SJ; Lansdorp PM; Young NS
    N Engl J Med; 2005 Apr; 352(14):1413-24. PubMed ID: 15814878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Telomere length variation and telomerase activity expression in patients with congenital and acquired aplastic anemia.
    Polychronopoulou S; Koutroumba P
    Acta Haematol; 2004; 111(3):125-31. PubMed ID: 15034232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical mutations in the TERT and TERC genes coding for telomerase components induced oxidative stress, DNA damage at telomeres and cell apoptosis besides decreased telomerase activity.
    Fernández-Varas B; Manguan-García C; Rodriguez-Centeno J; Mendoza-Lupiáñez L; Calatayud J; Perona R; Martín-Martínez M; Gutierrez-Rodriguez M; Benítez-Buelga C; Sastre L
    Hum Mol Genet; 2024 Apr; 33(9):818-834. PubMed ID: 38641551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conditional TRF1 knockout in the hematopoietic compartment leads to bone marrow failure and recapitulates clinical features of dyskeratosis congenita.
    Beier F; Foronda M; Martinez P; Blasco MA
    Blood; 2012 Oct; 120(15):2990-3000. PubMed ID: 22932806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dyskeratosis congenita -- a disease of dysfunctional telomere maintenance.
    Mason PJ; Wilson DB; Bessler M
    Curr Mol Med; 2005 Mar; 5(2):159-70. PubMed ID: 15974869
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A spectrum of severe familial liver disorders associate with telomerase mutations.
    Calado RT; Regal JA; Kleiner DE; Schrump DS; Peterson NR; Pons V; Chanock SJ; Lansdorp PM; Young NS
    PLoS One; 2009 Nov; 4(11):e7926. PubMed ID: 19936245
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dyskeratosis congenita: telomerase, telomeres and anticipation.
    Marrone A; Walne A; Dokal I
    Curr Opin Genet Dev; 2005 Jun; 15(3):249-57. PubMed ID: 15917199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dyskeratosis congenita.
    Bessler M; Wilson DB; Mason PJ
    FEBS Lett; 2010 Sep; 584(17):3831-8. PubMed ID: 20493861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders.
    Ballew BJ; Savage SA
    Expert Rev Hematol; 2013 Jun; 6(3):327-37. PubMed ID: 23782086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita.
    Alter BP; Baerlocher GM; Savage SA; Chanock SJ; Weksler BB; Willner JP; Peters JA; Giri N; Lansdorp PM
    Blood; 2007 Sep; 110(5):1439-47. PubMed ID: 17468339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disease anticipation is associated with progressive telomere shortening in families with dyskeratosis congenita due to mutations in TERC.
    Vulliamy T; Marrone A; Szydlo R; Walne A; Mason PJ; Dokal I
    Nat Genet; 2004 May; 36(5):447-9. PubMed ID: 15098033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetics and clinical manifestations of telomere biology disorders.
    Savage SA; Bertuch AA
    Genet Med; 2010 Dec; 12(12):753-64. PubMed ID: 21189492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proliferative defects in dyskeratosis congenita skin keratinocytes are corrected by expression of the telomerase reverse transcriptase, TERT, or by activation of endogenous telomerase through expression of papillomavirus E6/E7 or the telomerase RNA component, TERC.
    Gourronc FA; Robertson mM; Herrig AK; Lansdorp PM; Goldman FD; Klingelhutz AJ
    Exp Dermatol; 2010 Mar; 19(3):279-88. PubMed ID: 19558498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Telomere dysfunction and hematologic disorders.
    Paiva RM; Calado RT
    Prog Mol Biol Transl Sci; 2014; 125():133-57. PubMed ID: 24993701
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere length in inherited bone marrow failure syndromes.
    Alter BP; Giri N; Savage SA; Rosenberg PS
    Haematologica; 2015 Jan; 100(1):49-54. PubMed ID: 25304614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Telomerase reverse transcriptase haploinsufficiency and telomere length in individuals with 5p- syndrome.
    Du HY; Idol R; Robledo S; Ivanovich J; An P; Londono-Vallejo A; Wilson DB; Mason PJ; Bessler M
    Aging Cell; 2007 Oct; 6(5):689-97. PubMed ID: 17875000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of telomere attrition in patients with aplastic anemia.
    Scheinberg P
    Int J Hematol; 2013 May; 97(5):553-7. PubMed ID: 23636667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short telomeres resulting from heritable mutations in the telomerase reverse transcriptase gene predispose for a variety of malignancies.
    Hills M; Lansdorp PM
    Ann N Y Acad Sci; 2009 Sep; 1176():178-90. PubMed ID: 19796246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Understanding telomere diseases through analysis of patient-derived iPS cells.
    Batista LF; Artandi SE
    Curr Opin Genet Dev; 2013 Oct; 23(5):526-33. PubMed ID: 23993228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compound heterozygosity for two new TERT mutations in a patient with aplastic anemia.
    Aspesi A; Vallero S; Rocci A; Pavesi E; Lanciotti M; Ramenghi U; Dianzani I
    Pediatr Blood Cancer; 2010 Sep; 55(3):550-3. PubMed ID: 20658629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.